Clinical activity, safety and predictive biomarkers results from a phase Ia atezolizumab (atezo) trial in extensive-stage small cell lung cancer (ES-SCLC)

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sequist, LV; Chiang, A; Gilbert, J; Gordon, M; Conkling, PR; Thompson, D; Marcoux, JP; Antonia, SJ; Liu, B; Shames, DS; Lopez-Chavez, A; O'Hear, C; Fasso, M; Gettinger, S

Published Date

  • October 1, 2016

Published In

Volume / Issue

  • 27 /

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdw389.3